What does the merger between Sigma Healthcare and Chemist Warehouse mean for you - greater access to cheaper medicines or the loss of community pharmacies?
Dale Gillham
 | Dale Gillham is chief investment analyst at Wealth Within Limited (AFSL 226347). He also serves as the head trainer at Wealth Within (RTO 21917). He has more than three decades of experience in the investment industry and is the author of How to Beat the Managed Funds by 20%. Dale's qualifications include an Advanced Diploma and a Diploma of Share Trading and Investment. He co-hosts the Talking Wealth Podcast, and his work has appeared in The Australian Financial Review, New York Business Journal, Wall Street Select and more. Connect with Dale Gillham on LinkedIn. |
Showing 61 to 70 of 254 results for Dale Gillham:
With Donald Trump focused on boosting US energy independence, American energy exports could shrink, leaving room for Australia to step in and fill global demand.
Microcaps are companies with a market capitalisation of less than $500 million, so what are the top five microcaps on the ASX?
With defence spending forecast to rise in the coming years, which ASX-listed companies could be set to benefit?
Now could be the right time for you to take a closer look at some of the biggest players in the Australian energy sector.
Did Rio Tinto overpay with its $9.9 billion acquisition of Arcadium Lithium, or could this bold move be one of the best deals we've seen in recent times?
Qantas was one of the worst-performing stocks on the ASX this week, down more than 6%, so what were the best-performing stocks?
Removing negative gearing would likely cause a seismic shift in investor behaviour. So which shares would flourish and which would falter?
A controversial discussion in the US election debate about fracking could be the turning point Australia's largest gas companies have been waiting for.
After more than tripling in value over six months before reaching their peak in June, NVIDIA shares have tumbled, so what are the home-grown alternatives?
